SAFE Act

Bill: 118-hr-568
Sponsor: Rep. Pappas, Chris [D-NH-1]
Introduced: 2023-01-26 in the House
Policy area: Crime and Law Enforcement
Subjects: Administrative law and regulatory procedures
Congressional oversight
Criminal procedure and sentencing
Department of Justice
Drug trafficking and controlled substances
Government studies and investigations
International law and treaties
Licensing and registrations
Manufacturing
Research administration and funding

Summary:
action_date: 2023-01-26
text: 

Save Americans from the Fentanyl Emergency Act or the SAFE Act

 
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.
 
It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. 
 
The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including
 
 
permitting a single registration for related research sites in certain circumstances, 
 
waiving the requirement for a new inspection in certain situations, and 
 
allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. 
 
 
Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act. 


Legislative actions:
action_date: 2023-02-03
text: Referred to the Subcommittee on Health.
action_date: 2023-02-01
text: Sponsor introductory remarks on measure. (CR H588)
action_date: 2023-01-26
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2023-01-26
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2023-01-26
text: Introduced in House
action_date: 2023-01-26
text: Introduced in House